Identification of a Prognostic Model Based on Immune Cell Signatures in Clear Cell Renal Cell Carcinoma

Figure 9

Analysis of drug sensitivity in the training cohort. (a–i) Differences in IC50 of the chemotherapeutic drugs.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)